Mainz Biomed B.V. (MYNZ) NASDAQ
3.59
+0.03(+0.84%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
3.59
+0.03(+0.84%)
Currency In USD
| Market Cap | 6.72M |
| Enterprise Value | 8.4M |
| P/E Ratio | -3.47 |
| PEG Ratio | -0.03 |
| Price/Sales Ratio | 108.03 |
| Price/Book Ratio | 6.36 |
| Enterprise/Revenue | 92.96 |
| Enterprise/EBITDA | -3.55 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -29.38 |
| Operating Margin | -27.24 |
| Return On Assets | -1.09 |
| Return On Equity | -2.44 |
| Revenue | 537,080 |
| Revenue/Share | 0.02 |
| Gross Profit | -225,928 |
| EBITDA | -12.88M |
| Net Income | -16.21M |
| Diluted EPS | -2.7 |
| Total Cash | 889,091 |
| Total Cash/Share | 0.38 |
| Total Debt | 2.57M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 2.11 |
| Book Value Per Share | 0.39 |
| 52-Week Change | 75.98 |
| 52-Week High | 5.34 |
| 52-Week Low | 0.55 |
| Moving Average 50 Days | 0.97 |
| Moving Average 200 Days | 1.38 |
| Average Volume | 554,368 |
| Shares Outstanding | 4.09M |
| % Held by Institutions | 5.04 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:40 |
| Last Split Date | December 03, 2024 |